Embryonic epicardial cells (EPCs) can facilitate cardiomyocyte growth through secreting several essential growth factors, and participate in cardiac development through auto-differentiating into many cardiac cell lineages. Proper proliferation of EPCs is the precondition of these functions, so it is quite necessary to explore the mechanisms involving in EPC proliferation. In this study, we aimed to explore whether insulin-like growth factor 1 receptor (IGF1R) signaling participated in regulating the proliferation of EPCs. Our results showed that the expressions of IGF1R and its ligands IGF1 and IGF2 can be clearly spotted on the epicardium layer from E11.5d to E17.5d. Inhibition of IGF1R signaling using picropodophyllin or NVP-AEW541 significantly decreased the proliferation activity and blocked the cell cycle progression of epicardial cells in vitro. On the contrary, activating IGF1R with recombinant IGF1 and IGF2 promoted epicardial cell proliferation and cell cycle. We also found that decreased expression and phosphorylation of FAK in IGF1R inhibitor-treated cells and use of FAK inhibitor Y15 could significantly inhibit the IGFs-induced EPC proliferation. In conclusion, our results suggest that IGF1R signaling plays an important role in regulating EPC proliferation, and this effect may be mediated by FAK pathway.
Introduction
Epicardium, the outermost layer of heart, originates from the proepicardium, a cluster of coelomic progenitor cells located at the venous pole of embryonic heart. Apart from acting as an integral part of heart, embryonic epicardium can also facilitate cardiomyocyte growth through secreting paracrine factors and undergo epithelialto-mesenchymal transition (EMT) to form a pool of cells with multipotential differentiation, epicardial-derived cells (EPDCs), which mainly contribute to the cardiac interstitial cells and coronary smooth muscle cells [1] [2] [3] . EPDCs have been demonstrated to play a crucial role in building myocardial fiber framework, annulus fibrosus and atrioventricular valves, and as a result, ensure the atria and ventricle contract sequentially and maintain the normal atrioventricular blood flow exchange [4, 5] . In addition, the role of embryonic epicardial cells (EPCs) in coronary vasculogenesis has been identified [6] . Previous studies have also suggested that EPCs can differentiate into coronary endothelial cells and cardiomyocytes, but these findings are still in dispute [3, 7, 8] . Adult quiescent epicardium was found to reactivate and re-express embryonic epicardial markers, like WT1 and Tbx18, after cardiac amputation or myocardial infarction, and then may participate in promoting cardiac cell proliferation and neovascularization [9, 10] . Because of its excellent effects on embryogenesis and potential roles in cardiac regeneration, embryonic epicardium has already become a hot research topic.
Since proper proliferation of EPCs is the precondition of their physiologic functions, further exploring the proliferative mechanisms of EPCs seems quite necessary. Pro-mitogenic factors like fibroblast growth factor (FGF) and platelet-derived growth factor (PDGF) have already been proven to mainly affect EPCs, EMT, migration of EPDCs and vasculature formation, but no significant effect was observed in promoting EPC proliferation [11, 12] . Instead, they might be required for epicardial cell proliferation in regenerating the hearts of neonatal mouse and zebrafish [13, 14] . As one of the well-studied pro-mitogenic pathways, insulin-like growth factor 1 receptor (IGF1R) signaling has been shown to regulate the proliferation activity of many kinds of cells, but whether it participates in EPCs growth seems unclear.
During embryonic development, IGF1R signaling plays an important role in cell growth. IGF1R null mice weigh only 45% of wild-type ones at birth, and die within a few hours after birth because of respiratory failure together with organ hypoplasia [15] . It has also been demonstrated that IGF1R signaling can regulate embryonic development by promoting cell survival and progression in zebrafish [16] . Patients with homozygous mutation of IGF1R presented severe intrauterine growth retardation and persistent short stature [17] . Moreover, conditional disruption of IGF1R and insulin receptor (INSR) genes in the myocardium results in a significant decrease of embryonic myocardial proliferation and causes ventricular wall hypoplasia [2] . Inhibition of IGF1R signaling significantly reduces the IGF-induced mesoderm and endothelial precursor cell formation from stem cells in vitro, and further decreases the vascular development in differentiated embryoid bodies [18] . It has also been shown that IGF2 signals through IGF1R and plays overlapping roles in angiogenesis and cardiac outflow tract development in zebrafish embryos [19] . So, we speculated that IGF1R signaling also might play a role in EPC proliferation and embryonic epicardium growth.
Focal adhesion kinase (FAK) is a cytoplasmic tyrosine kinase that participates in cell motility, migration, and proliferation [20] . FAK contains a central kinase domain flanked by an N-terminal FERM domain and a C-terminal region. The activation of FAK starts with disruption of an auto-inhibitory intra-molecular interaction between kinase domain and FERM domain and autophosphorylation of tyrosine 397 (Y397) on N-terminal [21] . N-terminal domain of FAK has been shown to closely associate with the β-subunit of integrin and growth factors which enables FAK to integrate diverse cellular signals [22, 23] . Several studies have been carried out to assess the connection between IGF1R and FAK. One study showed that the intracellular β-subunits of IGF1R can directly bind to the NT2 domain of FAK to modulate cell growth [24] . In addition, IGF1R and FAK were found to interact with each other via insulin receptor substrate 1 (IRS-1) [25] . IGF1R/FAK signaling has been proven to play important roles in promoting cell growth in cancer cells [26, 27] . Whether IGF1R signals can regulate EPC proliferation through FAK pathway needs to be clarified. After being washed with PBS, the sections were incubated with goat anti-rabbit IgG (Cy3-conjugated; 1:100; CWBIO, Beijing, China) at 37°C for 1 h and mounted with DAPI (Invitrogen, Carlsbad, USA). EPCs cultured on the coverslips were fixed in 4% PFA at room temperature for 20 min and then washed with PBS. Permeabilization with 0.25% Triton X-100 was performed for Tbx18, Wt1, and Ki67 detection. Then, for all other primary antibodies, the cells were blocked with 10% goat serum in PBS for 30 min at 37°C and incubated with specific antibodies overnight at 4°C. Next, the coverslips were washed with PBS, incubated with second antibody for 40 min at 37°C and stained with DAPI for 5 min at room temperature. Primary antibodies were rabbit antibodies against: Tbx18 ( 
Materials and Methods

Mice embryos preparation
Quantitative real-time PCR
Total RNA of the cells was primarily extracted using Trizol reagent (TaKaRa, Dalian, China) according to the manufacturer's instructions. cDNA was prepared from 1 μg of total RNA using the PrimeScript Reverse Transcriptase Reagent kit (TaKaRa). qRT-PCR was performed to evaluate the relative levels of mRNA with SYBR premix Ex Taq II mix (TaKaRa) and C1000 thermal cycler (BioRad, Hercules, USA). The reaction condition was 95°C for 30 s, followed by 40 cycles of 95°C for 5 s and 60°C for 30 s, and then 65°C
for 5 s and ended with 95°C. Primers for Ki67, Ptk2, and Ptk2b were obtained from Sangon Biotech (Shanghai, China). GAPDH was used as the internal control and the relative gene expression was calculated using the 2 −ΔΔCT method. The primer sequences were as follows:
Ki67-F: 5′-ATCCAGCTGCCTGTAGTGTC-3′ and Ki67-R: 5′-AGGAGCGGTCAATGATGGTT-3′; Ptk2-F: 5′-GAAGAACGGATG AGGATGGA-3′ and Ptk2-R: 5′-ACTGGATCTCGGGCTAGGAT-3′; and Ptk2b-F: 5′-GGGACACTACCTGGAACGAA-3′ and Ptk2b-R: 5′-GCACACAGTTGATGCTCTCC-3′.
Cell counting kit-8 assay
Primary EPCs were trypsinized and resuspended at a concentration of 5 × 10 4 cells/ml in DMEM with 10% FBS. A total of 100 μl cell suspension was added into each well of 96-well plates, cultured (37°C, 5% CO 2 ) overnight, and subsequently starved for 12 h in serum-free DMEM. To determine whether IGF1R/FAK signaling participates in cell proliferation, the cells were treated with various doses of picropodophyllin (0, 0.2, 0.4, 0.8, and 1.6 μM; Selleck, Houston, USA) and NVP-AEW541 (0, 0.5, 1.0, 2.5, and 5 μM; Selleck) dissolved in 10% FBS, recombinant mouse IGF1 (0, 5, 10, and 50 ng/ml; R&D), and IGF2 (0, 10, 50, and 100 ng/ml; R&D, Minneapolis, USA) with or without Y15 (1 nM; Medchem Express, Monmouth Junction, USA) prepared in 1% FBS for 72 h. Then, 10 μl of cell counting kit-8 (CCK-8) solution (Dojindo, Tokyo, Japan) was added to each well and continuously incubated for another 4 h. The optical density (OD) value of each well was measured with an automatic microplate reader (Bio-Rad, Hercules, USA).
Flow cytometry
Cells were cultured with different interventions for 72 h. At the time point of interest, cells were collected after being washed with PBS, trypsinized, and centrifuged for three times to discharge the supernatant. Then, 1 ml of 75% ethanol (pre-cooled at −20°C) was slowly dripped into the tube to fix and resuspend the cells at a concentration of 1 × 10 6 cells/ml. Cell cycle profiles were analyzed by propidium iodide and fluorescence intensity was recorded by Cell Quest software (BD Biosciences, Franklin Lakes, USA).
Statistical analysis
Data were expressed as the mean ± SD. Student's t-test was used to compare the differences between two groups and one-way ANOVA was used to compare the differences between more than two groups. All data were analyzed with SPSS 21.0, and a P-value of <0.05 was considered to be statistically significant.
Results
IGF1R and its ligands in embryonic epicardium and primary EPCs
The expressions of IGF1R and its main ligands IGF1 and IGF2 in Tbx18:Cre/R26R EYFP fetal mouse heart were examined using immunofluorescence analyses. IGF1R, IGF1, and IGF2 all could be visually spotted at the epicardium layer from E11.5d to E17.5d period (Fig. 1) . Steady expression of IGF1R was detected during this time. IGF1 was weakly expressed on E11.5d and E12.5d, but then could be clearly detected from E13.5d. As an embryonic growth factor, IGF2 was expressed more apparently than IGF1. After cell harvest, the identification of primarily cultured EPCs was carried out using immunofluorescence staining of specific epicardial markers, Tbx18 and Wt1. And the number of positive cells was counted from five random fields with high-magnification. The immunofluorescence staining results showed that the cultured cells highly expressed Tbx18 and Wt1 ( Supplementary Fig. S1 ), and the positive cell proportions were 99.14% ± 1.13% and 99.32% ± 0.93%, respectively, indicating that the cells we obtained were indeed EPCs with high purity. Then, the expression of IGF1R was examined in EPCs.
Results showed that IGF1R dotted on the cytomembrane and the expressions of IGF1 and IGF2 could be observed alongside the cell membrane (Fig. 2) .
IGF1R inhibitor inhibits the proliferation of EPCs
In (Fig. 3A,B,D) . RT-PCR results indicated that the RNA expression levels of Ki67 in picropodophyllin group and NVP-AEW541 group were significantly lower than that in the control group (P < 0.05, respectively) (Fig. 3C) . In addition, immunofluorescence staining results showed significantly less Ki67 expression in cell nucleus in both the picropodophyllin group and the NVP-AEW541 group (Fig. 3D) . To probe deeply into the effects of IGF1R on proliferation, cell cycle was examined by flow cytometry. As shown in Fig. 3E ,F, picropodophyllin and NVP-AEW541 markedly increased the percentage of G1-phase cells and decreased the proportions of S and G2-phase cells (P < 0.05), indicating a possible role of IGF1R signaling in promoting cell cycle.
IGF1R inhibitor decreases the expression and phosphorylation of FAK
To determine whether FAK participates in the IGF1R signalingmediated proliferation procedure, the expression and phosphorylation of FAK were examined. RT-PCR results showed that the expressions of Ptk2 and Ptk2b which encoded FAK proteins were significantly decreased both in 0.4 μM picropodphyllin and 0.5 μM NVP-AEW541 groups (P < 0.05; Fig. 3C ). In addition, we used immunofluorescence to test the FAK phosphorylation at Y397 site (the most common phosphorylation site of FAK) and found that picropodophyllin and NVP-AEW541 significantly reduced the phosphorylation of FAK (Fig. 3D ).
IGF1 and IGF2 promotes the proliferation of EPCs
The results of CCK8 assays demonstrated a dose-dependent proliferative response both in IGF1-and IGF2-treated cells, in which the number of cells was significantly increased with 10 or 50 ng/ml IGF1 and 100 ng/ml IGF2 (Fig. 4A) . RT-PCR analysis showed that the expression of Ki67 gene was increased in cells treated with 50 ng/ml IGF1 or 100 ng/ml IGF2 when compared with the control cells (P < 0.05; Fig. 4B ). Similarly, immunofluorescence staining also showed an increased expression of Ki67 protein in the nucleus in both the IGF1 group and IGF2 group (Fig. 3D) . In addition, treatment with IGF1 or IGF2 could significantly promote cell cycle, with decreased G1-phase cell percentage and increased S and G2-phase cell percentages (Fig. 4E,F) . 
IGF1R and its ligands in embryonic epicardium
Immunofluorescence analyses of the expressions of IGF1R and its high-affinity ligands, IGF1 and IGF2, in Tbx18:Cre/R26REYFP embryonic heart tissues, which can trace the expression of specific epicardial marker Tbx18 through emitting green fluorescence. All these three proteins tagged with red fluorescence could be distinctively observed at the epicardial layer and could merge with the green fluorescence from E11.5d to E17.5d. Scale bars = 100 μm. Small pictures in the lower-right corner were the 1.5-fold amplification of the squared area. 
FAK is involved in IGFs-mediated proliferation of EPCs
After 72 h of culture with 50 ng/ml IGF1 or 100 ng/ml IGF2, EPCs were found to express more Ptk2 and Ptk2b as revealed by RT-PCR analysis, nearly 2-to 3-folds of that in the control cells (Fig. 4B) . In addition, the results of the immunofluorescence analysis demonstrated stronger intensity of FAK phosphorylation in both IGF1-and IGF2-treated cells (Fig. 4D ). All the above findings revealed that IGF1R activation could trigger the expression and phosphorylation of FAK, which indicated an important role of FAK in mediating IGF1R signaling. To testify the role of FAK in IGF1R-activated proliferative reaction in EPCs, a novel small molecule FAK phosphorylation inhibitor Y15 (1 nM) was added into the cell supernatant in combination with IGF1 or IGF2. CCK-8 assays demonstrated a significant decline in OD values in IGF1+Y15 and IGF2+Y15 groups in comparison with the corresponding groups in which the cells only received IGF1 or IGF2 treatment (Fig. 4C) . Moreover, as demonstrated by the RT-PCR and immunofluorescence analysis, combined use of Y15 significantly blocked the ability of IGF1 or IGF2 to elevate the expression of Ki67 at both mRNA and protein levels (Fig. 4B,D) . Meanwhile, flow cytometry results showed that Y15 induced a significant increase in G1-phase cell ratio and decline in S-and G2-phase cell ratio (P < 0.05), when compared with IGF1 or IGF2 treatment (Fig. 4E,F) . Thus, these results showed that FAK pathway may play an important role in mediating IGFs-induced cell proliferation.
Discussion
In this study, we mainly focused on the effects of IGF1R signaling on EPC proliferation and explored whether FAK participates in mediating this effect. Both IGF1R and its two main ligands were obviously expressed at the embryonic epicardium layer from E11.5d to E17.5d, which ran across the whole developmental period of epicardium. Inhibition of IGF1R signaling with picropodophyllin or NVP-AEW541 significantly decreased the proliferation activity and blocked the cell cycle progression of epicardial cells in vitro. On the contrary, activating IGF1R with recombinant IGF1 and IGF2 promoted epicardial cell proliferation and cell cycle progression. Moreover, our findings indicated a crucial role of FAK pathway in IGF1R-involved cell proliferation. Inhibition of IGF1R significantly decreased the expression and phosphorylation of FAK. The IGF1-or IGF2-induced cell proliferation and cell cycle progression were blocked by FAK inhibitor Y15 which specifically suppressed the phosphorylation of FAK at the Y397 site. Embryonic epicardium plays an important role in promoting cardiomyocyte proliferation through secreting growth factors [1, 2] and serving as a source of progenitors which contribute to myocardial interstitial fibroblast, coronary vascular smooth muscle cells, vascular endothelium cells and probably cardiomyocytes [3, 8] . Disruption of embryonic epicardium development totally results in abnormal cardiac morphology and function [28] . Moreover, epicardium cells also play important roles in mediating cardiac regeneration. Studies in zebrafish, which is capable of completing heart regeneration, revealed a reactivation of epicardium characterized with re-expressed embryonic epicardial markers Raldh2 and Tbx18 in the regenerating heart. Proliferation is also detected from 3 to 7 dpa in the activated epicardium [10] . Similarly, the quiescent mammalian epicardium can also be reactivated and starts to express embryonic markers after myocardial infarction [29] [30] [31] . Although it has been shown that the formed EPDCs of adult mouse after myocardial infarction fail to migrate into the myocardium, these cells may participate in modulating myocardial regeneration by secreting paracrine factors [32] . The potential effects of epicardium on cardiac regeneration provide a possible therapy for myocardial infarction. Thus, comprehensive understanding of the mechanisms involved in embryonic epicardium proliferation seems quite important for us to make a further exploration of the therapeutic role of epicardial cells. IGF1R is an important membrane tyrosine kinase receptor that mediates multiple biological molecular signaling transductions and participates in various physiological responses. IGF1R has been shown to play vital roles in the regulation of embryonic and cardiovascular development. Overexpression of IGF1R specifically in the mouse heart produces cardiac hypertrophy and an increase of cardiomyocyte size [33] . Conversely, loss of IGF1 or IGF2 in mice led to a growth deficiency in the same severity and the embryos was ~60% of normal birth weight. And mice lacking IGF1R exhibited a more severe growth deficiency (45% the weight of wild-type mates) and died at birth with organ dysplasia [15] . Several previous studies also indicated that IGF1R signaling participated in organogenesis. Disruption of IGF1R in zebrafish and Xenopus resulted in not only smaller embryos, but also disrupted head and central nervous system development [34] [35] [36] . The role of IGF1R signaling in cardiovascular development has also been determined. In both mice and zebrafish embryonic heart, the expressions of IGF1R system constituents could be distinctly detected. In zebrafish, IGF2 morphant embryos had defective blood circulation, atrioventricular boundary specification, and cardiac looping [19] , and knocking down of IGF-1a and IGF-1b resulted in retarded heart morphogenesis [16] . Mice with individual deficiency of IGF2 and combined conditional disruption of IGF1R and INSR had a significant decrease of ventricular wall proliferation and manifested with ventricular wall hypoplasia. In the same study, IGF1R, IGF1, and IGF2 genes were distinctly detected by in situ hybridization in the epicardial cells from E11.5d to E14.5d, which ranges from complete epicardium formation to coronary vascular network formation. This is the main time period for epicardial cells to undergo proliferation, EMT, migration and differentiation [2] . In our study, we checked the IGF1R and its ligands expressions at protein levels using immunofluorescence and found that the IGF1R system components were expressed not restricted to E11.5d-E14.5d, but also in the late stage of cardiogenesis, in which epicardium would expand according to the myocardial volume augmenting. These findings suggest that IGF1R signaling may potentially be involved in the developmental and physiological processes of embryonic epicardium in an autocrine manner. A crucial role of IGF1 signaling in promoting cell proliferation has been recognized in many kinds of cells. But its effects on epicardial cells have never been identified. Since epicardium is the main source of IGFs which are the most potent mitogen for cardiomyocytes, it may take an important role in cardiogenesis. A previous study showed that Nkx2.5Cre/IGF1R/INSR conditional mutant mice exhibited more severe ventricular wall thinning, when compared with the MLC2vCre/IGF1R/INSR conditional mutants [2] . MLC2vCre activity is restricted to the ventricular myocardium, but Nkx2.5Cre is active in myocardium and also in the epicardium and endocardium. This difference suggests that deficiency of IGF1R/ INSR signaling in epicardium may partially contribute to myocardium dysplasia and further indicates an important role of IGF1R signaling in epicardium development. In our study, we emphatically explored the role of IGF1R signaling in epicardial cell proliferation in vitro, and our results revealed that IGF1R indeed participated in promoting cell proliferation.
The two main downstream intracellular pathways of IGF1R are the phosphatidylinositol 3 kinase (PI3K) pathway and mitogenactivated protein kinase (MAPK) pathway, which have already been demonstrated to play important roles in promoting cell proliferation. Several previous studies have shown that the biological effects promoted by IGF1R, such as increasing cell invasive potential and regulating EMT process, could be mediated by FAK signaling [27, 37] . FAK was found to interact with IGF1R in regulating cell growth. The protein interaction between FAK and IGF1R was checked by a series of pull-down assay using GST-tagged FAK fragments and His-tagged IGF1R intracellular fragments and the results indicated that the FAK-NT2 domain directly interacted with the Nterminus of IGF1R intercellular domain [24] . Disruption of this protein interaction with a novel small molecular (INT2-31) significantly decreased cell proliferation, inhibited cell cycle progression and induced cell apoptosis in vivo [26] . Our results also demonstrated that FAK participated in mediating IGF1R-promoted EPC proliferation and cell cycle progression. IGF1R was shown to have significant effects on FAK autophosphorylation and mRNA expression. The effect of FAK on cardiac morphogenesis has also been indentified by establishing mice mutants with a conditional deletion of FAK in cardiomyocytes. Both MLC2aCre/FAK and Nkx2.5Cre/FAK mutants manifested with a thin ventricular wall, ventricular septal defects and associated mal-alignments of the outflow tract [38, 39] , suggesting a pivotal role of FAK in promoting myocardial cell growth. Our findings additionally indicated an involvement of FAK in the regulation of epicardium development.
FAK undergoes autophosphorylation at Y397 site and activates a number of downstream signaling pathways, which have been shown to play important roles in the regulation of cell proliferation. FAK binding to the SH2 domain of Src leads to the activation of Src through relieving the auto-inhibitory interaction. The formation of FAK/Src in turn phosphorylates FAK at Y925 site to mediate its interaction with Grb2 and finally leads to the activation of RAS-Erk signaling pathway [40] . FAK can also bind to the P85 subunit of PI3K and activate its downstream kinase Akt [41] . Activated Akt kinase regulates the function of many substances associated with cell cycle progression at the G1/S and G2/M transitions, either by direct phosphorylation of the target proteins, or indirectly by regulating protein expression levels [42] . Jun N-terminal kinase (JNK), a subtype of MAPK, has also been demonstrated to mediate FAKassociated cell proliferation through G1-phase of cell cycle [43] . In addition, the transcription factor KLF8 has been indentified as a downstream target of FAK in the cell cycle progression by activating the cyclin D1 promoter [44] . All these findings suggest that the interaction of IGF1R with FAK may lead to an augmentation of cascade signaling pathways in regulating cell proliferation.
In conclusion, in this study we demonstrated that IGF1R signaling plays an essential role in regulating the proliferation of EPCs, and that FAK may participate in this process.
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